Retinoblastom

erstellt am 10.03.2014, Zuletzt geändert:  29.06.2022

Studienliteratur Retinoblastom

 Suche nach Artikeln in den letzten sechs Monaten in PubMed (externes Informationsangebot)
  1. Grümme L, Biewald E, Reschke M, Fischhuber K, Hanbücken A, Schlüter S, Müller B, Kiefer T, Göricke S, Geismar D, Ryl T, Sirin S, Wieland R, Timmermann B, Lohmann D, Ebinger M, Brecht IB, Schönberger S, Schwab C, Eggert A, Süsskind D, Ritter-Sovinz P, Bechrakis NE, Ketteler P: Comparing efficacy and side effects of two systemic chemotherapy regimens for eye-preserving therapy in children with retinoblastoma. Pediatric blood & cancer 2022, 69:e29362 [PMID: 34606174] GRU2022
  2. Biewald E, Kiefer T, Geismar D, Schlüter S, Manthey A, Westekemper H, Wulff J, Timmermann B, Ketteler P, Schönberger S, Metz KA, Ting S, Göricke S, Bechrakis NE, Bornfeld N: Feasibility of Proton Beam Therapy as a Rescue Therapy in Heavily Pre-Treated Retinoblastoma Eyes. Cancers 2021 Apr 13; 13 [PMID: 33924716] BIE2021a
  3. Opitz M, Bos D, Deuschl C, Radbruch A, Zensen S, Sirin S, Forsting M, Bechrakis N, Biewald E, Bornfeld N, Ketteler P, Timmermann B, Stuschke M, Guberina M, Wetter A, Göricke S, Guberina N: Estimation of radiation exposure of children undergoing superselective intra-arterial chemotherapy for retinoblastoma treatment: assessment of local diagnostic reference levels as a function of age, sex, and interventional success. Neuroradiology 2021, 63: 391 [PMID: 32862237] OPI2021
  4. Reschke M, Biewald E, Bronstein L, Brecht IB, Dittner-Moormann S, Driever F, Ebinger M, Fleischhack G, Grabow D, Geismar D, Göricke S, Guberina M, Le Guin CHD, Kiefer T, Kratz CP, Metz K, Müller B, Ryl T, Schlamann M, Schlüter S, Schönberger S, Schulte JH, Sirin S, Süsskind D, Timmermann B, Ting S, Wackernagel W, Wieland R, Zenker M, Zeschnigk M, Reinhardt D, Eggert A, Ritter-Sovinz P, Lohmann DR, Bornfeld N, Bechrakis N, Ketteler P: Eye Tumors in Childhood as First Sign of Tumor Predisposition Syndromes: Insights from an Observational Study Conducted in Germany and Austria. Cancers 2021 Apr 14; 13 [PMID: 33919815] RES2021
  5. Hülsenbeck I, Frank M, Biewald E, Kanber D, Lohmann DR, Ketteler P: Introduction of a Variant Classification System for Analysis of Genotype-Phenotype Relationships in Heritable Retinoblastoma. Cancers 2021 Mar 31; 13 [PMID: 33807189] HUE2021
  6. Kiefer T, Schlüter S, Bechrakis NE, Bornfeld N, Göricke S, Ketteler P, Ting S, Geismar D, Biewald E: Intraarterial Chemotherapy for Retinoblastoma - Initial Experiences of a German Reference Centre. Klinische Monatsblatter fur Augenheilkunde 2021, 238: 788 [PMID: 34376009] KIE2021
  7. Dittner-Moormann S, Reschke M, Abbink FCH, Aerts I, Atalay HT, Fedorovna Bobrova N, Biewald E, Brecht IB, Caspi S, Cassoux N, Castela G, Diarra Y, Duncan C, Ebinger M, Garcia Aldana D, Hadjistilianou D, Kepák T, Klett A, Kiratli H, Maka E, Opocher E, Pawinska-Wasikowska K, Rascon J, Russo I, Rutynowska-Pronicka O, Sábado Álvarez C, Pacheco SSR, Svojgr K, Timmermann B, Vishnevskia-Dai V, Eggert A, Ritter-Sovinz P, Bechrakis NE, Jenkinson H, Moll A, Munier FL, Popovic MB, Chantada G, Doz F, Ketteler P: Adjuvant therapy of histopathological risk factors of retinoblastoma in Europe: A survey by the European Retinoblastoma Group (EURbG). Pediatric blood & cancer 2021, 68:e28963 [PMID: 33720495] DIT2021
  8. Ketteler P, Hülsenbeck I, Frank M, Schmidt B, Jöckel KH, Lohmann DR: The impact of RB1 genotype on incidence of second tumours in heritable retinoblastoma. European journal of cancer (Oxford, England : 1990) 2020, 133: 47 [PMID: 32434110] KET2020
  9. Bornfeld N, Biewald E, Bauer S, Temming P, Lohmann D, Zeschnigk M: The Interdisciplinary Diagnosis and Treatment of Intraocular Tumors. Deutsches Arzteblatt international 2018 Feb 16; 115: 106 [PMID: 29510820] BOR2018
  10. Temming P, Eggert A: Retinoblastom, in: Niemeyer C, Eggert A (Hrsg.): Pädiatrische Hämatologie und Onkologie. Springer-Verlag GmbH Deutschland 2018 [ISBN: 978-3-662-43686-8] TEM2018
  11. Schwermer M, Dreesmann S, Eggert A, Althoff K, Steenpass L, Schramm A, Schulte JH, Temming P: Pharmaceutically inhibiting polo-like kinase 1 exerts a broad anti-tumour activity in retinoblastoma cell lines. Clinical & experimental ophthalmology 2017, 45: 288 [PMID: 27647547] SCH2017a
  12. Temming P, Arendt M, Viehmann A, Eisele L, Le Guin CH, Schündeln MM, Biewald E, Astrahantseff K, Wieland R, Bornfeld N, Sauerwein W, Eggert A, Jöckel KH, Lohmann DR: Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: A report from the German reference center. Pediatric blood & cancer 2017, 64: 71 [PMID: 27567086] TEM2017
  13. Sirin S, de Jong MC, de Graaf P, Brisse HJ, Galluzzi P, Maeder P, Bornfeld N, Biewald E, Metz KA, Temming P, Castelijns JA, Goericke SL, European Retinoblastoma Imaging Collaboration: High-Resolution Magnetic Resonance Imaging Can Reliably Detect Orbital Tumor Recurrence after Enucleation in Children with Retinoblastoma. Ophthalmology 2016, 123: 635 [PMID: 26692298] SIR2016
  14. Temming P, Arendt M, Viehmann A, Eisele L, Le Guin CH, Schündeln MM, Biewald E, Mäusert J, Wieland R, Bornfeld N, Sauerwein W, Eggert A, Lohmann DR, Jöckel KH: How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Jul 5; [PMID: 27382102] TEM2016
  15. Schündeln MM, Hauffa PK, Bauer JJ, Temming P, Sauerwein W, Biewald E, Bornfeld N, Hauffa BP, Grasemann C: Pediatric Survivors of Retinoblastoma Are at Risk for Altered Bone Metabolism After Chemotherapy Treatment Early in Life. Pediatric hematology and oncology 2015, 32: 455 [PMID: 26237585] SCH2015c
  16. Temming P, Viehmann A, Arendt M, Eisele L, Spix C, Bornfeld N, Sauerwein W, Jöckel KH, Lohmann DR: Pediatric second primary malignancies after retinoblastoma treatment. Pediatric blood & cancer 2015, 62: 1799 [PMID: 25970657] TEM2015
  17. Künkele A, Wilm J, Holdt M, Lohmann D, Bornfeld N, Eggert A, Temming P, Schulte JH: Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre. The British journal of ophthalmology 2015,Epub ahead of print [PMID: 25583279] KUE2015
  18. Temming P, Eggert A, Bornfeld N, Sauerwein W, Göricke S, Lohmann DR: [Diagnosis and treatment of retinoblastoma: current strategies for effective tumour control and preservation of vision]. Klinische Monatsblatter fur Augenheilkunde 2013, 230: 232 [PMID: 23508752] TEM2013a
  19. Temming P, Viehmann A, Biewald E, Lohmann DR: Sporadic unilateral retinoblastoma or first sign of bilateral disease? Br J Ophthalmol 2013, 97: 475 [PMID: 23355526] TEM2013
  20. Temming P, Corson TW, Lohmann DR: Retinoblastoma tumorigenesis: genetic and epigenetic changes walk hand in hand. Future oncology (London, England) 2012, 8: 525 [PMID: 22646767] TEM2012
  21. Wieland R, Havers W: Retinoblastome. In: Gadner H, Gaedicke G, Niemeyer CH, Ritter J (Hrsg.): Pädiatrische Hämatologie und Onkologie. Springer-Verlag 2006, 823 [ISBN: 3540037020] WIE2004
  22. Kremens B, Wieland R, Reinhard H, Neubert D, Beck JD, Klingebiel T, Bornfeld N, Havers W: High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma. Bone marrow transplantation 2003, 31: 281 [PMID: 12621463] KRE2003a